Ticagrelor (Brilinta) Tablet Side Effects (Nuksanat)
Ticagrelor (Brilinta) is an antiplatelet medicine — its action is to inhibit platelets, so bleeding is an expected outcome. The most important and characteristic side effect is dyspnoea (breathlessness) which occurs only with ticagrelor and is often mistaken for bronchospasm — it is NOT bronchospasm.
Characteristic Side Effect: Dyspnoea (Sans Phoolna)
Ticagrelor causes breathlessness in 15–20% of patients:
- Mechanism: Adenosine accumulation — ticagrelor inhibits adenosine uptake
- What it is NOT: Bronchospasm, asthma attack, heart failure
- Onset: Usually within the first week
- Course: Often resolves on its own — if persistent, see a cardiologist
- Action: Generally do NOT stop the medicine — there is a risk of stent thrombosis
- Exception: Severe or worsening dyspnoea — cardiologist evaluation is essential
Common Side Effects (Aam Nuksanat)
- Dyspnoea / breathlessness — 15–20% of patients; adenosine-mediated; NOT bronchospasm; usually self-limiting
- Bleeding — bruising, nosebleed, excessive bleeding from minor cuts
- GI bleeding — dark stools, blood in stool
- Headache
- Dizziness
- Nausea
- Hyperuricaemia — mild, usually asymptomatic; rarely gout
These side effects are generally manageable. Inform your doctor but do not stop on your own.
Uncommon Side Effects
- Ventricular pauses — usually short, asymptomatic (Holter monitoring data shows this)
- Sinus bradycardia (slow heart rate — adenosine)
- Hypotension
- Confusion (rare)
Serious Side Effects (Sanjeedah Nuksanat — Emergency)
- Major bleeding — intracranial haemorrhage (severe headache, neurological signs) — EMERGENCY
- Fatal GI bleeding — black tarry stools, vomiting blood — seek care immediately
- Severe dyspnoea — rare; requires urgent cardiologist evaluation
- Ventricular pauses with haemodynamic compromise — rare; pacemaker consideration
When to See a Doctor (Kab Doctor Se Milna Zaroori Hai)
- Excessive or unusual bleeding — stop and seek care
- Severe or rapidly worsening breathlessness
- Severe bradycardia or fainting
- Sudden severe chest pain
- Black or tarry stools, vomiting blood
- Severe headache, vision changes, arm/leg weakness (intracranial bleeding — EMERGENCY)
Warnings and Precautions (Ihtiyat)
- Inform surgical/dental teams — stop 5 days before elective procedures
- Do not take Aspirin >100mg — reduces ticagrelor efficacy
- Avoid strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin)
- CONTRAINDICATED if previous intracranial haemorrhage
- No antidote available — platelet transfusion is considered in bleeding emergencies
Side Effects Summary Table
| Type | Side Effect | Action |
|---|---|---|
| Common | Dyspnoea (breathlessness) | Inform cardiologist — often do not stop |
| Common | Bruising, nosebleed | Monitor; inform doctor |
| Common | GI bleeding (dark stools) | See a doctor immediately |
| Uncommon | Ventricular pauses | Usually asymptomatic — monitor |
| Serious | Major bleeding (intracranial/GI) | EMERGENCY — 1122 |
| Serious | Severe dyspnoea | See cardiologist immediately |
| Critical | Stent thrombosis (if stopped) | EMERGENCY — 1122 |
Reporting Side Effects
If you notice any unexpected side effect, report it on the DRAP pharmacovigilance portal: https://www.dra.gov.pk/pharmacovigilance
The information in this guide is for educational purposes only. If you notice any side effect, contact your doctor or pharmacist.